CA2420614A1 - Biphenylsulfonamides et leurs derives qui modulent l'activite de l'endotheline - Google Patents

Biphenylsulfonamides et leurs derives qui modulent l'activite de l'endotheline Download PDF

Info

Publication number
CA2420614A1
CA2420614A1 CA 2420614 CA2420614A CA2420614A1 CA 2420614 A1 CA2420614 A1 CA 2420614A1 CA 2420614 CA2420614 CA 2420614 CA 2420614 A CA2420614 A CA 2420614A CA 2420614 A1 CA2420614 A1 CA 2420614A1
Authority
CA
Canada
Prior art keywords
compound
pharmaceutically acceptable
hydrogen
acid
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2420614
Other languages
English (en)
Inventor
Adam Kois
Timothy Kogan
Vitukudi Narayanaiyengar Balaji
Bore Gowda Raju
Rosario Silverste Castillo
Ming Fai Chan
Venkatachalapathi Yalamoori
Chengde Wu
Erik Joel Verner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Encysive Pharmaceuticals Inc
Original Assignee
Texas Biotechnology Corporation
Adam Kois
Timothy Kogan
Vitukudi Narayanaiyengar Balaji
Bore Gowda Raju
Rosario Silverste Castillo
Ming Fai Chan
Venkatachalapathi Yalamoori
Chengde Wu
Erik Joel Verner
Immunopharmaceutics, Inc.
Encysive Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/477,226 external-priority patent/US6176874B1/en
Application filed by Texas Biotechnology Corporation, Adam Kois, Timothy Kogan, Vitukudi Narayanaiyengar Balaji, Bore Gowda Raju, Rosario Silverste Castillo, Ming Fai Chan, Venkatachalapathi Yalamoori, Chengde Wu, Erik Joel Verner, Immunopharmaceutics, Inc., Encysive Pharmaceuticals Inc. filed Critical Texas Biotechnology Corporation
Publication of CA2420614A1 publication Critical patent/CA2420614A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA 2420614 1995-04-04 1996-04-04 Biphenylsulfonamides et leurs derives qui modulent l'activite de l'endotheline Abandoned CA2420614A1 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US41619995A 1995-04-04 1995-04-04
US41707595A 1995-04-04 1995-04-04
US08/416,199 1995-04-04
US08/417,075 1995-04-04
US08/477,226 1995-06-06
US08/477,226 US6176874B1 (en) 1993-10-18 1995-06-07 Vascularized tissue regeneration matrices formed by solid free form fabrication techniques

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002288439A Division CA2288439C (fr) 1995-04-04 1996-04-04 Biphenyl sulfonamides et leurs derives modulant l'activite de l'endotheline

Publications (1)

Publication Number Publication Date
CA2420614A1 true CA2420614A1 (fr) 1996-10-10

Family

ID=27411090

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2420614 Abandoned CA2420614A1 (fr) 1995-04-04 1996-04-04 Biphenylsulfonamides et leurs derives qui modulent l'activite de l'endotheline

Country Status (1)

Country Link
CA (1) CA2420614A1 (fr)

Similar Documents

Publication Publication Date Title
CA2217169C (fr) Thienyl-, furyl-, pyrrolyl- et biphenyl sulfonamides et leurs derives modulant l'activite de l'endotheline
US6331637B1 (en) N-Alkyl, N-Alkenyl, N-Alkynyl, N-Aryl and N-fused bicyclo or tricyclo thienyl-, furyl-,and Pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5594021A (en) Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
RU2151144C1 (ru) Сульфонамиды, фармацевтическая композиция на их основе, способ лечения эндотелин-зависимых заболеваний, способ ингибирования связывания эндотелинового пептида с эндотелин a-(етa) или b-(етb) рецепторами, способ изменения вызываемой эндотелиновыми рецепторами активности.
US6683103B2 (en) Sulfonamides for treatment of endothelin-mediated disorders
US5571821A (en) Sulfonamides and derivatives thereof that modulate the activity of endothelin
US6248767B1 (en) Formulation of sulfonamides for treatment of endothelin-mediated disorders
US6613804B2 (en) Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US6342610B2 (en) N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
CA2420614A1 (fr) Biphenylsulfonamides et leurs derives qui modulent l'activite de l'endotheline
CA2288439C (fr) Biphenyl sulfonamides et leurs derives modulant l'activite de l'endotheline
AU726595B2 (en) Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead